TRPV1 Agonist Approaches for Pain Management

Vanilloid Receptor TRPV1 in Drug Discovery: Targeting Pain and Other Pathological Disorders

Volumn , Issue , 2010, Pages 325-347

  Bley, Keith R ^a  

^a NeurogesX Inc   (United States)

Author keywords

TRPV1 agonist approaches for pain management; TRPV1 agonist based therapies viability unlikely, side effect profile of defunctionalization, unlikely to be acceptable; TRPV1 agonist induced disruption of nociceptor hyperactivity

Indexed keywords

EID: 77956040484     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470588284.ch13     Document Type: Chapter

References (112)

1. Ali Z, Ringkamp M, Hartke TV, Chien HF, Flavahan NA, Campbell JN, and Meyer RA (1999) Uninjured C - fiber nociceptors develop spontaneous activity and alpha - adrenergic sensitivity following L6 spinal nerve ligation in monkey. J Neurophysiol 81: 455 - 466.
2. Anesiva (2008) Adlea: Long - lasting, Non - Opioid Analgesic. http://www.anesiva.com/ wt/page/adlea (accessed January 2009).
3. Babbar S, Marier JF, Mouksassi MS, Beliveau M, Vanhove GF, Chanda S, Bley K (2009) Pharmacokinetic analysis of capsaicin after topical administration of a high - concentration capsaicin patch to patients with peripheral neuropathic pain. Ther Drug Monit 31: 502 - 510.
4. Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Philip Malan P Jr., Rauck P, and Tobias J, and the NGX - 4010 C116 Study Group (2009) A double - blind controlled study of a single application of NGX - 4010, a high - concentration capsaicin patch, for the treatment of postherpetic neuralgia. Lancet Neurol 7: 1106 - 1112.
5. Bennett GJ (1998) Neuropathic pain: new insights, new interventions. Hosp Pract (Off Ed) 33: 95 - 110.
6. Birder LA, Kanai AJ, de Groat WC, Kiss S, Nealen ML, Burke NE, Dineley KE, Watkins S, Reynolds IJ, and Caterina MJ (2001) Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci U S A 98: 13396 - 13401.
7. Bjerring P, Arendt - Nielsen L, and Soderberg U (1990) Argon laser induced cutaneous sensory and pain thresholds in post - herpetic neuralgia. Quantitative modulation by topical capsaicin. Acta Derm Venereol 70: 121 - 125.
8. Bohm - Starke N, Hilliges M, Brodda - Jansen G, Rylander E, and Torebjork E (2001) Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain 94: 177 - 183.
9. Bohm - Starke N, Hilliges M, Falconer C, and Rylander E (1998) Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 46: 256 - 260.
10. Bonnington JK and McNaughton PA (2003) Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol 551 (Pt 2): 433 - 446.
11. Bowles WR, Sabino M, Harding - Rose C, and Hargreaves KM (2006) Chronic nerve growth factor administration increases the peripheral exocytotic activity of capsaicin - sensitive cutaneous neurons. Neurosci Lett 403: 305 - 308.
12. Brady CM, Apostolidis A, Yiangou Y, Baecker PA, Ford AP, Freeman A, Jacques TS, Fowler CJ, and Anand P (2004) P2X3 - immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin. Eur Urol 46: 247 - 253.
13. Brand L, Berman E, Schwen R, Loomans M, Janusz J, Bohne R, Maddin C, Gardner J, Lahann T, and Farmer R (1987) NE - 19550: a novel, orally active anti - inflammatory analgesic. Drugs Exp Clin Res 13: 259 - 265.
14. Campbell JN (2001) Nerve lesions and the generation of pain. Muscle Nerve 24: 1261 - 1273.
15. Candido K and Stevens RA (2003) Intrathecal neurolytic blocks for the relief of cancer pain. Best Pract Res Clin Anaesthesiol 17: 407 - 428.
16. Chan CL, Facer P, Davis JB, Smith GD, Egerton J, Bountra C, Williams NS, and Anand P (2003) Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 361: 385 - 391.
17. Chancellor MB (2000) Discussion: resiniferatoxin - preliminary data. Urology 55 (Suppl 5A): 65.
18. Chancellor MB and de Groat WC (1999) Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol 162: 3 - 11.
19. Christmas TJ, Rode J, Chapple CR, Milroy EJ, and Turner - Warwick RT (1990) Nerve fibre proliferation in interstitial cystitis. Virchows Arch A Pathol Anat Histopathol 416: 447 - 451.
20. Cordell GA and Araujo OE (1993) Capsaicin: identification, nomenclature, and pharmacotherapy. Ann Pharmacother 27: 330 - 336.
21. Cruz F (2004) Mechanisms involved in new therapies for overactive bladder. Urology 63 (3 Suppl 1): 65 - 73.
22. Dasgupta P, Chandiramani VA, Beckett A, Scaravilli F, and Fowler CJ (2000) The effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyperreflexia. BJU Int 85: 238 - 245.
23. de Groat WC (1997) A neurologic basis for the overactive bladder. Urology 50 (Suppl 6A): 36 - 52.
24. Diamond S, Freitag F, Phillips SB, Bernstein JE, and Saper JR (2000) Intranasal civamide for the acute treatment of migraine headache. Cephalalgia 20: 597 - 602.
25. Dmitrieva N and McMahon SB (1996) Sensitisation of visceral afferents by nerve growth factor in the adult rat. Pain 66: 87 - 97.
26. Dux M, Sann H, Schemann M, and Jancso G (1999) Changes in fibre populations of the rat hairy skin following selective chemodenervation by capsaicin. Cell Tissue Res 296: 471 - 477.
27. Engler A, Aeschlimann A, Simmen BR, Michel BA, Gay RE, Gay S, and Sprott H (2007) Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis. Biochem Biophys Res Commun 359: 884 - 888.
28. Fernihough J, Gentry C, Bevan S, and Winter J (2005) Regulation of calcitonin gene - related peptide and TRPV1 in a rat model of osteoarthritis. Neurosci Lett 388: 75 - 80.
29. Fusco BM, Barzoi G, and Agr ò F (2003) Repeated intranasal capsaicin applications to treat chronic migraine. Br J Anaesth 90: 812.
30. Gosling JA, Gilpin SA, Dixon JS, and Gilpin CJ (1986) Decrease in the autonomic innervation of human detrusor muscle in outflow obstruction. J Urol 136: 501 - 504.
31. Hagbarth KE (2002) Microelectrode recordings from human peripheral nerves (microneurography). Muscle Nerve Suppl 11: S28 - S35.
32. Han P, McDonald HA, Bianchi BR, Kouhen RE, Vos MH, Jarvis MF, Faltynek CR, and Moreland RB (2007) Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes. Biochem Pharmacol 73: 1635 - 1645.
33. Hempenstall K, Nurmikko TJ, Johnson RW, A ' Hern RP, and Rice AS (2005) Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2: e164.
34. Hendiani JA, Westlund KN, Lawand N, Goel N, Lisse J, and McNearney T (2003) Mechanical sensation and pain thresholds in patients with chronic arthropathies. J Pain 4: 203 - 211.
35. Holzer P (2008) The pharmacological challenge to tame the transient receptor potential vanilloid - 1 (TRPV1) nocisensor. Br J Pharmacol 155: 1145 - 1162.
36. Hua XY, Chen P, Hwang J, and Yaksh TL (1997) Antinociception induced by civamide, an orally active capsaicin analogue. Pain 71: 313 - 322.
37. Iannone F and Lapadula G (2003) The pathophysiology of osteoarthritis. Aging Clin Exp Res 15: 364 - 372.
38. ICOS Corporation (2003) Reports Results for 2003. http://www.corporate-ir.net/ireye/ ir_site.zhtml?ticker=ICOS&script=410&layout=0&item_id=491321&sstring=resini feratoxin (accessed February 2005).
39. Jaggar SI, Scott HC, and Rice AS (1999) Inflammation of the rat urinary bladder is associated with a referred thermal hyperalgesia which is nerve growth factor dependent. Br J Anaesth 83: 442 - 448.
40. Janusz JM, Buckwalter BL, Young PA, Lahann TR, Farmer RW, Kasting GB, Loomans ME, Kerckaert GA, Maddin CS, and Berman EF (1993) Vanilloids. 1. Analogs of capsaicin with antinociceptive and antiinflammatory activity. J Med Chem 36: 2595 - 2604.
41. Ji RR, Samad TA, Jin SX, Schmoll R, and Woolf CJ (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36: 57 - 68.
42. Johanek L, Shim B, and Meyer RA (2006) Primary hyperalgesia and nociceptor sensitization. In Pain: Handbook of Clinical Neurology, Vol. 81 (Cervero F and Jensen T, eds.), pp. 35 - 47. Elsevier, Philadelphia, PA.
43. Karai L, Brown DC, Mannes AJ, Connelly ST, Brown J, Gandal M, Wellisch OM, Neubert JK, Olah Z, and Iadarola MJ (2004) Deletion of vanilloid receptor 1 - expressing primary afferent neurons for pain control. J Clin Invest 113: 1344 - 1352.
44. Kawakami T, Hikawa N, Kusakabe T, Kano M, Bandou Y, Gotoh H, and Takenaka T (1993) Mechanism of inhibitory action of capsaicin on particulate axoplasmic transport in sensory neurons in culture. J Neurobiol 24: 545 - 551.
45. Kennedy WR (2004) Opportunities afforded by the study of unmyelinated nerves in skin and other organs. Muscle Nerve 29: 756 - 767.
46. Kennedy WR, Wendelschafer - Crabb G, and Johnson T (1996) Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47: 1042 - 1048.
47. Kim JH, Rivas DA, Shenot PJ, Green B, Kennelly M, Erickson JR, O'Leary M, Yoshimura N, and Chancellor MB (2003) Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo - controlled trial. J Spinal Cord Med 26: 358 - 363.
48. Lamb K, Gebhart GF, and Bielefeldt K (2004) Increased nerve growth factor expression triggers bladder overactivity. J Pain 5: 150 - 156.
49. Lauria G, Morbin M, Lombardi R, Capobianco R, Camozzi F, Pareyson D, Manconi M, and Geppetti P (2006) Expression of capsaicin receptor immunoreactivity in human peripheral nervous system and in painful neuropathies J Peripher Nerv Syst 11: 262 - 267.
50. Lazzeri M, Beneforti P, and Turini D (1997) Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor. J Urol 158: 2093 - 2096.
51. Lindenlaub T and Sommer C (2002) Epidermal innervation density after partial sciatic nerve lesion and pain - related behavior in the rat. Acta Neuropathol (Berl) 104: 137 - 143.
52. Lysy J, Sistiery - Ittah M, Israelit Y, Shmueli A, Strauss - Liviatan N, Mindrul V, Keret D, and Goldin E (2003) Topical capsaicin - a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study. Gut 52: 1323 - 1326.
53. MacDonald R, Monga M, Fink HA, and Wilt TJ (2008) Neurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: a systematic review of effectiveness and adverse effects. J Spinal Cord Med 31: 157 - 165.
54. Maggi CA, Barbanti G, Santicioli P, Beneforti P, Misuri D, Meli A, and Turini D (1989) Cystometric evidence that capsaicin - sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol 142: 150 - 154.
55. Malmberg AB, Mizisin AP, Calcutt NA, Von Stein T, Robbins WR, and Bley KR (2004) Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high - concentration capsaicin patch. Pain 111: 360 - 367.
56. Manni L, Lundeberg T, Fiorito S, Bonini S, Vigneti E, and Aloe L (2003) Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor - alpha, interleukin - 1 beta and cholecystokinin - 8: the possible role of NGF in the inflammatory response. Clin Exp Rheumatol 21: 617 - 624.
57. Masheb RM, Nash JM, Brondolo E, and Kerns RD (2000) Vulvodynia: an introduction and critical review of a chronic pain condition. Pain 86: 3 - 10.
58. Mason L, Moore RA, Derry S, Edwards JE, and McQuay HJ (2004) Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 328: 991 - 994.
59. Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, and Anand P (2004) Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 16: 897 - 902.
60. Merskey H and Bogduk N (1994) Pain terms: a current list with definitions and notes on usage. In Classification of Chronic Pain, 2nd ed. (Merskey H and Bogduk N, eds.), pp. 209 - 214. IASP Press, Seattle, WA.
61. Michaelis M (2002) Electrophysiological characteristics of injured peripheral nerves. In Mechanisms and Mediators of Neuropathic Pain (Malmberg AB and Chaplan SR, eds.), pp. 3 - 22. Birkh ä user Verlag, Basel.
62. Miller MS, Buck SH, Sipes IG, Yamamura HI, and Burks TF (1982) Regulation of substance P by nerve growth factor: disruption by capsaicin. Brain Res 250: 193 - 196.
63. Mukerji G, Yiangou Y, Agarwal SK, and Anand P (2006) Transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome and its correlation with pain. J Urol 176: 797 - 801.
64. Murina F, Radici G, and Bianco V (2004) Capsaicin and the treatment of vulvar vestibulitis syndrome: a valuable alternative? MedGenMed 6: 48.
65. NeurogesX (2008) NGX - 4010: Beyond Conventional Pain Therapy. http://www. neurogesx.com/wt/page/ngx_4010 (accessed January 2009).
66. NeurogesX (2009) NeurogesX receives European Commission approval for Qutenza ™. Press release. May 21, 2009. http://ngsx.client.shareholder.com/ releasedetail.cfm?ReleaseID=385457 (accessed October 2009).
67. Niv D, Gofeld M, and Devor M (2003) Causes of pain in degenerative bone and joint disease: a lesson from vertebroplasty. Pain 105: 387 - 392.
68. Nolano M, Simone DA, Wendelschafer - Crabb G, Johnson T, Hazen E, and Kennedy WR (1999) Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 81: 135 - 145.
69. Oaklander AL (2001) The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain 92: 139 - 145.
70. Ochoa JL, Campero M, Serra J, and Bostock H (2005) Hyperexcitable polymodal and insensitive nociceptors in painful human neuropathy. Muscle Nerve 32: 459 - 472.
71. Orstavik K, Weidner C, Schmidt R, Schmelz M, Hilliges M, Jorum E, Handwerker H, and Torebjork E (2003) Pathological C - fibres in patients with a chronic painful condition. Brain 126 (Pt 3): 567 - 578.
72. Paice JA, Ferrans CE, Lashley FR, Shott S, Vizgirda V, and Pitrak D (2000) Topical capsaicin in the management of HIV - associated peripheral neuropathy. J Pain Symptom Manage 19: 45 - 52.
73. Petruska JC and Mendell LM (2004) The many functions of nerve growth factor: multiple actions on nociceptors. Neurosci Lett 361: 168 - 171.
74. Pincelli C (2000) Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol 10: 85 - 90.
75. Pittenger GL, Mehrabyan A, Simmons K, Rice AL, Dublin C, Barlow P, and Vinik AI (2005) Small fiber neuropathy is associated with the metabolic syndrome. Metab Syndr Relat Disord 3: 113 - 1121.
76. Pittenger GL, Ray M, Burcus NI, McNulty P, Basta B, and Vinik AI (2004) Intraepidermal nerve fibers are indicators of small - fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 27: 1974 - 1979.
77. Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, and McArthur JC (2004) The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 127 (Pt 7): 1606 - 1615.
78. Polydefkis M, Yiannoutsos CT, Cohen BA, Hollander H, Schifitto G, Clifford DB, Simpson DM, Katzenstein D, Shriver S, Hauer P, Brown A, Haidich AB, Moo L, and McArthur JC (2002) Reduced intraepidermal nerve fiber density in HIV - associated sensory neuropathy. Neurology 58: 115 - 119.
79. Rains C and Bryson HM (1995) Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post - herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 7: 317 - 328.
80. Ramer MS and Bisby MA (1999) Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti - NGF treatment. Eur J Neurosci 11: 837 - 846.
81. Remadevi R and Szallasi A (2008) Adlea (ALGRX - 4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief. IDrugs 11: 120 - 132.
82. Robbins WR, Staats PS, Levine J, Fields HL, Allen RW, Campbell JN, and Pappagallo M (1998) Treatment of intractable pain with topical large - dose capsaicin: preliminary report. Anesth Analg 86: 579 - 583.
83. Rowbotham MC, Yosipovitch G, Connolly MK, Finlay D, Forde G, and Fields HL (1996) Cutaneous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol Dis 3: 205 - 214.
84. Rutkowski JL, Tuite GF, Lincoln PM, Boyer PJ, Tennekoon GI, and Kunkel SL (1999) Signals for proinflammatory cytokine secretion by human Schwann cells. J Neuroimmunol 101: 47 - 60.
85. Saper JR, Klapper J, Mathew NT, Rapoport A, Phillips SB, and Bernstein JE (2002) Intranasal civamide for the treatment of episodic cluster headaches. Arch Neurol 59: 990 - 994.
86. Scott LJ, Griffin JW, Luciano C, Barton NW, Banerjee T, Crawford T, McArthur JC, Tournay A, and Schiffmann R (1999) Quantitative analysis of epidermal innervation in Fabry disease. Neurology 52: 1249 - 1254.
87. Shamash S, Reichert F, and Rotshenker S (2002) The cytokine network of Wallerian degeneration: tumor necrosis factor - alpha, interleukin - 1alpha, and interleukin - 1beta. J Neurosci 22: 3052 - 3060.
88. Shim B, Ringkamp M, Lambrinos GL, Hartke TV, Griffin JW, and Meyer RA (2007) Activity - dependent slowing of conduction velocity in uninjured L4 C fibers increases after an L5 spinal nerve injury in the rat. Pain 128: 40 - 51.
89. Simone DA, Nolano M, Johnson T, Wendelschafer - Crabb G, and Kennedy WR (1998) Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci 18: 8947 - 8959.
90. Simpson DM, Estanislao L, Brown SJ, and Sampson J (2008a) An open - label pilot study of high - concentration capsaicin patch in painful HIV neuropathy. J Pain Symptom Manage 35: 299 - 306.
91. Simpson DM, Brown S, and Tobias J, and NGX - 4010 C107 Study Group (2008b) Controlled trial of high - concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 70: 2305 - 2313.
92. Sonni L, Cattaneo A, De Marco A, De Magnis A, Carli P, and Marabini S (1995) Idiopathic vulvodynia. Clinical evaluation of the pain threshold with acetic acid solutions. J Reprod Med 40: 337 - 341.
93. Southall MD, Li T, Gharibova LS, Pei Y, Nicol GD, and Travers JB (2003) Activation of epidermal vanilloid receptor - 1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 304: 217 - 222.
94. Springall DR, Karanth SS, Kirkham N, Darley CR, and Polak JM (1991) Symptoms of notalgia paresthetica may be explained by increased dermal innervation. J Invest Dermatol 97: 555 - 561.
95. Steinberg AC, Oyama IA, Rejba A, Kellog - Spadt S, and Whitmore KE (2005) Capsaicin for the treatment of vulvar vestibulitis. Am J Obstet Gynecol 192: 1549 - 1553.
96. Szallasi A and Blumberg PM (1999) Resiniferatoxin, a phorbol - related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 30: 515 - 520.
97. Szallasi A and Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159 - 212.
98. Tanner R, Chambers P, Khadra MH, and Gillespie JI (2000) The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro. BJU Int 85: 1115 - 1119.
99. Taylor DC, Pierau FK, and Szolcsanyi J (1984) Long lasting inhibition of horseradish peroxidase (HRP) transport in sensory nerves induced by capsaicin pretreatment of the receptive field. Brain Res 298: 45 - 49.
100. Tender GC, Walbridge S, Olah Z, Karai L, Iadarola M, Oldfield EH, and Lonser RR (2005) Selective ablation of nociceptive neurons for elimination of hyperalgesia and neurogenic inflammation. J Neurosurg 102: 522 - 525.
101. Turnbull A (1850) Tincture of capsaicin as a remedy for chilblains and toothache. Dublin Free Press 1: 95 - 96.
102. Tympanidis P, Casula MA, Yiangou Y, Terenghi G, Dowd P, and Anand P (2004) Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain 8: 129 - 133.
103. Tympanidis P, Terenghi G, and Dowd P (2003) Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 148: 1021 - 1027.
104. Wall PD and Devor M (1983) Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain 17: 321 - 339.
105. Watkins LR and Maier SF (2002) Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82: 981 - 1011.
106. Winston Laboratories, Inc. (2005) Topical Civamide Cream 0.075% Effectively Reduces Osteoarthritis Pain without Harmful, Systemic Side Effects. Press release, January 25, 2005. http://www.biospace.com/news_story.aspx?NewsEntityId=18800820 (accessed October 2008).
107. Winston Laboratories, Inc. (2008) Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger. Press release, September 26, 2008. http://biz.yahoo.com/prnews/080926/clf023.html?v=101 (accessed January 2009).
108. Wu G, Ringkamp M, Hartke TV, Murinson BB, Campbell JN, Griffin JW, and Meyer RA (2001) Early onset of spontaneous activity in uninjured C - fiber nociceptors after injury to neighboring nerve fibers. J Neurosci 21: RC140.
109. Wu G, Ringkamp M, Murinson BB, Pogatzki EM, Hartke TV, Weerahandi HM, Campbell JN, Griffin JW, and Meyer RA (2002) Degeneration of myelinated efferent fibers induces spontaneous activity in uninjured C - fiber afferents. J Neurosci 22: 7746 - 7753.
110. Yiangou Y, Facer P, Ford A, Brady C, Wiseman O, Fowler CJ, and Anand P (2001) Capsaicin receptor VR1 and ATP - gated ion channel P2X3 in human urinary bladder. BJU Int 87: 774 - 779.
111. Yokoyama T, Nozaki K, Fujita O, Nose H, Inoue M, and Kumon H (2004) Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity. J Urol 172: 596 - 600.
112. Zhang WY and Li Wan Po A (1994) The effectiveness of topically applied capsaicin. A meta - analysis. Eur J Clin Pharmacol 46: 517 - 522.